These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30403413)

  • 1. Synthetic cannabinoid: an unexpected cause of coagulopathy.
    Tran MH; Perez-Alvarez I; Swaroop B
    Transfusion; 2018 Nov; 58(11):2743-2744. PubMed ID: 30403413
    [No Abstract]   [Full Text] [Related]  

  • 2. Coagulopathy After Synthetic Cannabinoid Use: A Case Report.
    Rasin A; Devgun JM; Nosal DG; Meehan TJ; van Breemen RB; Thompson TM
    Ann Intern Med; 2019 Oct; 171(8):595-596. PubMed ID: 31450243
    [No Abstract]   [Full Text] [Related]  

  • 3. "The 700-Dollar Vitamin": The Epidemic of Synthetic Cannabinoid-Associated Coagulopathy. A Case Study of Excessive Generic Drug Prices in the American Health Care System.
    Shanbhag S; Dane KE; Streiff MB
    Mayo Clin Proc; 2019 Feb; 94(2):199-201. PubMed ID: 30711118
    [No Abstract]   [Full Text] [Related]  

  • 4. Coagulopathic hemorrhage with use of synthetic cannabinoids.
    Boyack I; Opsha O
    Am J Emerg Med; 2019 Feb; 37(2):374.e3-374.e4. PubMed ID: 30409461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bad weed: synthetic cannabinoid-associated coagulopathy.
    Arepally GM; Ortel TL
    Blood; 2019 Feb; 133(9):902-905. PubMed ID: 30655273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor-guided diagnosis of coagulopathy associated with coumarin-contaminated synthetic cannabinoids.
    Torian SC; Hayes L; Negrete A
    Am J Emerg Med; 2022 Aug; 58():350.e5-350.e6. PubMed ID: 35577625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic Cannabinoid-Associated Coagulopathy.
    Kelkar AH; Tarantino MD; Roberts JC
    N Engl J Med; 2019 Jan; 380(1):101-102. PubMed ID: 30601754
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthetic Cannabinoid-Associated Coagulopathy.
    Wang JJ; Howland MA; Biary R
    N Engl J Med; 2019 Jan; 380(1):101. PubMed ID: 30601753
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthetic Cannabinoid-Associated Coagulopathy.
    Mycyk MB
    N Engl J Med; 2019 Jan; 380(1):100-101. PubMed ID: 30601752
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological properties and dependence liabilities of synthetic cannabinoids].
    Funada M
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2010 Jun; 45(3):167-74. PubMed ID: 20681249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 'spicy' encephalopathy: synthetic cannabinoids as cause of encephalopathy and seizure.
    Louh IK; Freeman WD
    Crit Care; 2014 Oct; 18(5):553. PubMed ID: 25673061
    [No Abstract]   [Full Text] [Related]  

  • 13. Lethal coagulopathy resulting from the consumption of contaminated synthetic cannabinoids: the story of a public health crisis.
    Fasih A
    J Public Health (Oxf); 2021 Apr; 43(1):e1-e6. PubMed ID: 31242305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic cannabinoid and marijuana exposures reported to poison centers.
    Forrester MB; Kleinschmidt K; Schwarz E; Young A
    Hum Exp Toxicol; 2012 Oct; 31(10):1006-11. PubMed ID: 22859662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone-induced hepatotoxicity in a patient addicted to synthetic cannabinoid.
    Saglam O; Bahsi R; Akkoca Y; Filik L
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):360-1. PubMed ID: 26825144
    [No Abstract]   [Full Text] [Related]  

  • 16. Brodifacoum-contaminated synthetic marijuana: clinical and radiologic manifestations of a public health outbreak causing life-threatening coagulopathy.
    Panigrahi B; Jones BC; Rowe SP
    Emerg Radiol; 2018 Dec; 25(6):715-718. PubMed ID: 30022308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosis and synthetic cannabinoids.
    Deng H; Verrico CD; Kosten TR; Nielsen DA
    Psychiatry Res; 2018 Oct; 268():400-412. PubMed ID: 30125871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Life-Threatening Bleeding and Deaths from Synthetic Cannabinoids.
    Zolot J
    Am J Nurs; 2019 Mar; 119(3):15. PubMed ID: 30801303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
    Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
    Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure.
    Gudsoorkar VS; Perez JA
    Methodist Debakey Cardiovasc J; 2015; 11(3):189-91. PubMed ID: 26634029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.